Mucosal Fixed Drug Eruption to Levetiracetam with Early Positive Patch Test on Non-Lesional Skin
Keyword(s):
Levetiracetam (LEV) is a second-generation antiepileptic drug (AED) that is well tolerated, has a broad spectrum of action, low protein binding, and minimal hepatic metabolism. The incidence of hypersensitivity to LEV in children and adults is 0.6%. This is the first reported fixed drug eruption (FDE) identified using a patch test in a pediatric case associated with LEV
2016 ◽
Vol 91
(5)
◽
pp. 652-654
◽
2013 ◽
Vol 41
(3)
◽
pp. 203-204
◽
2001 ◽
Vol 44
(4)
◽
pp. 246-263
◽
2017 ◽
Vol 28
(8)
◽
pp. 848-850
◽
2006 ◽
Vol 54
(2)
◽
pp. 127-128
◽
2001 ◽
Vol 44
(1)
◽
pp. 58-58
◽